Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Monosymptomatic clinically isolated syndrome with sudden sensorineural hearing loss: case report and critical review of the literature.
Improving Hand Functional Use in Subjects with Multiple Sclerosis Using a Musical Keyboard: A Randomized Controlled Trial.
Imaging In The Cell
Plasma Exchange in a Patient with Tumefactive, Corticosteroid-Resistant Multiple Sclerosis.
Safety, Tolerability and Efficacy of Monthly Long-acting IM Injection of 80 mg GA Depot in Subjects With RRMS
Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial.
The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia.
Gap junction pathology in multiple sclerosis lesions and normal-appearing white matter.
Olive oil phenols and neuroprotection.
Focused suggestion with somatic anchoring technique: rapid self-hypnosis for pain management.
Low-contrast visual tests reveal better alemtuzumab efficacy
Corticosteroids for treating optic neuritis.
Energy Cost of Walking and Its Association With Gait Parameters, Daily Activity, and Fatigue in Persons With Mild Multiple Sclerosis.
Plasma exchange in severe attacks of neuromyelitis optica.
Oligodendrocytes and the early multiple sclerosis lesion.
Effect of treatment with interferon beta-1a on changes in voxel-wise magnetization transfer ratio in normal appearing brain tissue and lesions of patients with relapsing-remitting multiple sclerosis: a 24-week, controlled pilot study.
Unraveling the secrets of white matter - Bridging the gap between cellular, animal and human imaging studies.
Teva and Takeda announce agreement for glatiramer acetate for multiple sclerosis treatment in Japan
RORγt(+) cells selectively express redundant cation channels linked to the Golgi apparatus.
In vivo evidence of glutamate toxicity in multiple sclerosis.
Evaluation of sexual function in women at two stages of multiple sclerosis.
Myelin Basic Protein-Specific TCR/HLA-DRB5*01:01 Transgenic Mice Support the Etiologic Role of DRB5*01:01 in Multiple Sclerosis.
Natalizumab in pediatric multiple sclerosis: results of a cohort of 55 cases.
Cost-effectiveness of natalizumab vs fingolimod for the treatment of relapsing-remitting multiple sclerosis: analyses in Sweden.
Modulation of Sox10, HIF-1α, Survivin, and YAP by Minocycline in the Treatment of Neurodevelopmental Handicaps following Hypoxic Insult.

Pages